Endovascular Today
Biotronik’s BIO-OSCAR FIRST Trial Begins Enrollment. December 19, 2024—Biotronik announced the enrollment of the first patients in its BIO-OSCAR FIRST trial, which is designed to confirm the safety and clinical performance of the company’s Oscar peripheral multifunctional catheter for dilation of lesions in the femoral, popliteal, and infrapopliteal arteries, including …
December 2024 Supplement - Endovascular Today
2 天之前 · December 2024 Supplement. Peripheral Arterial Clot? #POUNCEIT. When minutes matter – remove acute or chronic thrombi or emboli without aspiration, thrombolytics, or capital equipment.
News - Endovascular Today
6 天之前 · Biotronik’s BIO-OSCAR FIRST Trial Begins Enrollment. December 19, 2024—Biotronik announced the enrollment of the first patients in its BIO-OSCAR FIRST trial, which is designed to confirm the safety and clinical performance of the company’s Oscar peripheral multifunctional catheter for dilation of lesions in the femoral, popliteal, and infrapopliteal arteries, including …
November 2024 Issue - Endovascular Today
Initiatives to Improve Awareness of Aortic Dissection. Advocates with Aortic Hope/Think Aorta, The John Ritter Foundation for Aortic Health, and The Aortic Dissection Collaborative for Patient-Centered Research discuss how they are raising awareness of aortic …
AVENTUS Thrombectomy System: Innovative Endovascular …
The AVENTUS Thrombectomy System (Inquis Medical, Inc.) is a fully integrated, next-generation mechanical thrombectomy device consisting of a 24-F catheter, aspiration syringe, and a blood filtration chamber ().It is currently being evaluated in the United States as part of the AVENTUS Pivotal IDE (investigational device exemption) Study (NCT05907564) and has been cleared by …
December 2022 Issue - Endovascular Today
News and information on minimally invasive vascular disease therapies, covering peripheral vascular disease, aneurysms, stroke, hypertension, dialysis access, and venous issues.
Radial Access - Endovascular Today
2024年10月15日 · Radial Approach Evaluated With Terumo’s R2P Misago Stent to Treat Complex Lower Extremity PAD. September 27, 2022—Terumo Medical Corporation recently announced data demonstrating the safety and efficacy of radial to peripheral interventions with the company’s R2P Misago self-expanding peripheral stent in lower extremity endovascular …
Humacyte’s Symvess ATEV Approved by FDA for Treatment of …
5 天之前 · December 19, 2024—Humacyte, Inc. announced that the FDA has granted full approval for the company’s Symvess—acellular tissue engineered vessel-tyod (ATEV)—for use in adults as a vascular conduit for extremity arterial injury when urgent revascularization is needed to avoid imminent limb loss and when autologous vein graft is not feasible.
April 2022 Issue - Endovascular Today
Shape Memory Polymer: A New Solution for AAA Endoleak Management? Andrew Holden, MBChB, FRANZCR, EBIR, and Michel M.P.J. Reijnen, MD, PhD, discuss their clinical experience with shape memory polymer—a novel embolic material—for endoleak management and evaluating it for active abdominal aortic aneurysm sac management.
Venous - Endovascular Today
2024年11月11日 · Study Assesses Effects of Intravascular Volume Expansion on Deep Pelvic Vein Size. November 3, 2024—A study assessed the effects of intravascular volume expansion on deep pelvic vein size using the 200-150-125 rule for the cross-sectional area (CSA) of the common iliac, external iliac, and common femoral veins (CIV, EIV, and CFV), which was …